State-of-the-art surgery for hepatocellular carcinoma
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature..
BACKGROUND: Hepatocellular carcinoma (HCC) is the most commonly diagnosed primary liver tumor with an increasing incidence worldwide. Management of patients with HCC is largely dictated by the presence of cirrhosis, disease stage, underlying liver function, and patient performance status.
PURPOSE: We provide an update on key aspects of surgical treatment options for patients with HCC. RESULTS & CONCLUSIONS: Liver resection and transplantation remain cornerstone treatment options for patients with early-stage disease and constitute the only potentially curative options for HCC. Selection of patients for surgical treatment should include a thorough evaluation of tumor characteristics and biology, as well as evidence-based use of various available treatment options to achieve optimal long-term outcomes for patients with HCC.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:406 |
|---|---|
| Enthalten in: |
Langenbeck's archives of surgery - 406(2021), 7 vom: 18. Nov., Seite 2151-2162 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Machairas, Nikolaos [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cirrhosis |
|---|
| Anmerkungen: |
Date Completed 11.11.2021 Date Revised 11.11.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00423-021-02298-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329488597 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329488597 | ||
| 003 | DE-627 | ||
| 005 | 20231225205228.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00423-021-02298-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1098.xml |
| 035 | |a (DE-627)NLM329488597 | ||
| 035 | |a (NLM)34405284 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Machairas, Nikolaos |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a State-of-the-art surgery for hepatocellular carcinoma |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.11.2021 | ||
| 500 | |a Date Revised 11.11.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. | ||
| 520 | |a BACKGROUND: Hepatocellular carcinoma (HCC) is the most commonly diagnosed primary liver tumor with an increasing incidence worldwide. Management of patients with HCC is largely dictated by the presence of cirrhosis, disease stage, underlying liver function, and patient performance status | ||
| 520 | |a PURPOSE: We provide an update on key aspects of surgical treatment options for patients with HCC. RESULTS & CONCLUSIONS: Liver resection and transplantation remain cornerstone treatment options for patients with early-stage disease and constitute the only potentially curative options for HCC. Selection of patients for surgical treatment should include a thorough evaluation of tumor characteristics and biology, as well as evidence-based use of various available treatment options to achieve optimal long-term outcomes for patients with HCC | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cirrhosis | |
| 650 | 4 | |a Hepatectomy | |
| 650 | 4 | |a Hepatocellular carcinoma | |
| 650 | 4 | |a Liver transplantation | |
| 650 | 4 | |a Recurrence | |
| 650 | 4 | |a Survival | |
| 700 | 1 | |a Tsilimigras, Diamantis I |e verfasserin |4 aut | |
| 700 | 1 | |a Pawlik, Timothy M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Langenbeck's archives of surgery |d 1998 |g 406(2021), 7 vom: 18. Nov., Seite 2151-2162 |w (DE-627)NLM095673148 |x 1435-2451 |7 nnns |
| 773 | 1 | 8 | |g volume:406 |g year:2021 |g number:7 |g day:18 |g month:11 |g pages:2151-2162 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00423-021-02298-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 406 |j 2021 |e 7 |b 18 |c 11 |h 2151-2162 | ||